• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

M&A: NextGen Healthcare to Acquire TSI Healthcare for $68M

Share:

December 5, 2022

What You Should Know:

NextGen Healthcare today announced it has signed a definitive agreement to acquire TSI Healthcare, a privately held value-added reseller located in Chapel Hill, NC. The acquisition will expand NextGen’s presence in specialties including rheumatology, pulmonology and cardiology.

TSI Healthcare® is a national leader in the sales and support of customized NextGen® Practice Management and Electronic Health Record software. TSI Healthcare delivers innovative, specialty-specific solutions to maximize revenue, reduce costs, and advance patient care through unmatched customer service that focuses on the human element.

Financial Details

Under terms of the agreement, the acquisition comprised of an upfront amount of $68M, which will be paid in cash with contingent consideration of up to $22 million in cash in the form of an earnout, subject to achieving certain financial targets through March 31, 2025. The acquisition is expected to contribute approximately $10 to 12 million of revenue in the remaining four months of fiscal 2023 and will be accretive to adjusted EBITDA and cash flow within a year. The company plans to update guidance when it reports its fiscal 2023 third quarter results.

Source: Hit Consultant

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • UK COVID-19 Test Applications Delayed By DemandUK COVID-19 Test Applications Delayed By Demand
  • AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of MavupharmaAbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
  • BSM Partners Encourages Scientific Community to Perform Controlled, Original Research on Diet and Dilated Cardiomyopathy (DCM) in DogsBSM Partners Encourages Scientific Community to Perform Controlled, Original Research on Diet and Dilated Cardiomyopathy (DCM) in Dogs
  • Vision Innovation Partners Completes Fifteenth Acquisition, Adds Baltimore Practice and Surgery Center to Mid-Atlantic PlatformVision Innovation Partners Completes Fifteenth Acquisition, Adds Baltimore Practice and Surgery Center to Mid-Atlantic Platform
  • FDA Greenlights Bigfoot Biomedical’s Insulin Recommending Diabetes Management SystemFDA Greenlights Bigfoot Biomedical’s Insulin Recommending Diabetes Management System
  • Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in IndiaAjinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India
  • Mallinckrodt Completes Sale of BioVectra Inc. for up to $250 MillionMallinckrodt Completes Sale of BioVectra Inc. for up to $250 Million
  • Ginkgo Bioworks Completes Acquisition of ZymergenGinkgo Bioworks Completes Acquisition of Zymergen

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications